/SCNX
SCNX Stock - Scienture Holdings, Inc.
Healthcare|Medical - Healthcare Information ServicesNASDAQ
$0.57+14.47%
+$0.07 (+14.47%) • Dec 19
36
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.0
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.8
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.63
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for SCNX
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.56 – $0.58
TARGET (TP)$0.66
STOP LOSS$0.52
RISK/REWARD1:1.8
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta2.80
52W High$8.00
52W Low$0.46
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $136,643 | $1.36M | $10.25M | $9.89M | $17.12M |
| Gross Profit | $6,005 | $49,030 | $5.52M | $4.75M | $5.71M |
| Gross Margin | 4.4% | 3.6% | 53.8% | 48.0% | 33.3% |
| Operating Income | $-14,701,015 | $-4,396,451 | $-2,915,969 | $-5,292,293 | $-2,506,662 |
| Net Income | $9.07M | $-17,843,574 | $-3,472,099 | $-5,315,883 | $-2,536,051 |
| Net Margin | 6634.7% | -1308.3% | -33.9% | -53.8% | -14.8% |
| EPS | $2.69 | $-23.35 | $-6.15 | $-9.80 | $-4.94 |
Company Overview
TRxADE HEALTH, Inc. operates as health services IT company. It offers an online web-based buying and selling platform for licensed pharmaceutical wholesalers to sell brand, generic, and non-drug products and services to government organizations, hospitals, clinics and independent pharmacies. TRxADE HEALTH, Inc. is headquartered in Tampa, Florida.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
SCNXBeat Rate
0%
Last 8 quarters
Avg Surprise
-881.6%
EPS vs Estimate
Beats / Misses
0/8
Last 12 quarters
Latest EPS
$-0.19
Q4 2025
EPS Surprise History
Q4 23
No data
Q2 24
-4166.7%
$-6.40vs$-0.15
Q3 24
-593.3%
$-1.04vs$-0.15
Q4 24
-793.3%
$-1.34vs$-0.15
Q1 25
No data
Q2 25
No data
Q3 25
No data
Q4 25
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | May 11, 2026 | — | — | — | — |
Q4 2025 | Nov 12, 2025 | — | $-0.19 | — | — |
Q3 2025 | Aug 12, 2025 | — | $-0.48 | — | — |
Q2 2025 | May 12, 2025 | — | $-0.33 | — | — |
Q1 2025 | Mar 26, 2025 | — | $-0.82 | — | — |
Q4 2024 | Nov 6, 2024 | $-0.15 | $-1.34 | -793.3% | ✗ MISS |
Q3 2024 | Aug 9, 2024 | $-0.15 | $-1.04 | -593.3% | ✗ MISS |
Q2 2024 | Jun 26, 2024 | $-0.15 | $-6.40 | -4166.7% | ✗ MISS |
Q4 2023 | Dec 31, 2023 | — | $-4.93 | — | — |
Q3 2023 | Sep 30, 2023 | $-0.15 | $-1.49 | -894.4% | ✗ MISS |
Q2 2023 | Jun 30, 2023 | $-0.75 | $-2.90 | -286.5% | ✗ MISS |
Q1 2023 | Mar 31, 2023 | $-0.30 | $-1.01 | -236.9% | ✗ MISS |
Q4 2022 | Dec 31, 2022 | $-0.90 | $-1.50 | -66.4% | ✗ MISS |
Q3 2022 | Sep 30, 2022 | — | $-0.91 | — | — |
Q2 2022 | Jun 30, 2022 | $-1.73 | $-1.99 | -15.2% | ✗ MISS |
Q1 2022 | Mar 31, 2022 | — | $-1.76 | — | — |
Q4 2021 | Dec 31, 2021 | — | $-1.44 | — | — |
Q3 2021 | Sep 30, 2021 | — | $-2.39 | — | — |
Q2 2021 | Jun 30, 2021 | — | $-4.76 | — | — |
Q1 2021 | Mar 31, 2021 | — | $-1.21 | — | — |
Latest News
SCNX stock has given up its prior gain. Scienture Holdings shares were trading higher after the company announced a strategic collaboration with Blink Rx to expand national access to Arbli.
➖ NeutralBenzinga•Dec 10, 2025, 04:22 PM•Also:
Scienture Holdings shares are trading higher after the company announced a strategic collaboration with Blink Rx to expand national access to Arbli.
📈 PositiveBenzinga•Dec 10, 2025, 01:08 PM•Also:
SCIENTURE HOLDINGS Collaborates With BlinkRx For Expanded Patient Access To Arbli.
📈 PositiveBenzinga•Dec 10, 2025, 01:07 PM•Also:
Scienture Holdings Q3 EPS $(0.19) Up From $(1.34) YoY, Sales $590.050K Up From $64.861K YoY
📈 PositiveBenzinga•Nov 13, 2025, 01:21 PM•Also:
EXCLUSIVE: Scienture Tells Benzinga 'Gross profit increased from approximately $4 thousand to $575 thousand'
📈 PositiveBenzinga•Nov 13, 2025, 12:50 PM
EXCLUSIVE: Scienture Tells Benzinga 'Reports Significant Revenue Growth to $590K and Substantial Increase in Gross Profit to $575K'
📈 PositiveBenzinga•Nov 13, 2025, 12:50 PM
EXCLUSIVE: Scienture Tells Benzinga Co. Reports Q3 Financial Results And provides Business Update
➖ NeutralBenzinga•Nov 13, 2025, 12:50 PM
Scienture Holdings, Inc. shares are trading higher after the company announced that Arbli (losartan potassium) oral suspension was added to key national payor formularies, expanding commercial and Medicare coverage.
📈 PositiveBenzinga•Nov 4, 2025, 12:55 PM•Also:
EXCLUSIVE: SCIENTURE HOLDINGS Tells Benzinga 'Arbli Oral Suspension, 10 mg/mL has been added to the formularies of key national payors, expanding access through both multiple commercial coverage and Medicare supplement plans'
📈 PositiveBenzinga•Nov 4, 2025, 12:50 PM•Also:
EXCLUSIVE: SCIENTURE HOLDINGS Tells Benzinga Co. Announces Addition Of Arbli To Formularies Of Major National Health Plans, Says 'Expanded Coverage Reaches Over 100 Million Covered Lives Nationwide'
📈 PositiveBenzinga•Nov 4, 2025, 12:50 PM•Also:
Scienture Holdings Shares Halted On Circuit Breaker To The Upside, Stock Now Up 354.94%
📈 PositiveBenzinga•Oct 23, 2025, 07:46 PM•Also:
Scienture Holdings Shares Resume Trading, Halted Again On Circuit Breaker; Up 137%
📈 PositiveBenzinga•Oct 23, 2025, 03:17 PM•Also:
Scienture Holdings Shares Halted On Circuit Breaker To The Upside, Stock Now Up 183.46%
📈 PositiveBenzinga•Oct 23, 2025, 03:05 PM•Also:
Scienture shares are trading higher after the company announced the start of commercial sales and fulfillment of first orders for Arbli.
📈 PositiveBenzinga•Oct 23, 2025, 12:08 PM
EXCLUSIVE: SCIENTURE HOLDINGS Tells Benzinga 'Company launches multi-channel promotional campaign to drive market adoption'
📈 PositiveBenzinga•Oct 23, 2025, 11:50 AM•Also:
EXCLUSIVE: SCIENTURE HOLDINGS Tells Benzinga Co. Announces Start Of Commercial Sales And Fulfillment Of First Orders For Arbli
📈 PositiveBenzinga•Oct 23, 2025, 11:50 AM•Also:
SCIENTURE HOLDINGS Says Arbli Oral Suspension, 10mg/mL, Is Commercially Available Through Full-Line Wholesalers Nationwide
📈 PositiveBenzinga•Oct 16, 2025, 01:04 PM•Also:
Scienture Holdings Settles All Outstanding Debentures With Arena Investors Via Share Conversion At $2.4861/Share
➖ NeutralBenzinga•Oct 8, 2025, 01:08 PM•Also:
EXCLUSIVE: SCIENTURE HOLDINGS Tells Benzinga 'Represents potential penetration into ~ 20% of the U.S. institutional market, while broadening access across long-term care and outpatient facilities'
📈 PositiveBenzinga•Oct 1, 2025, 12:45 PM•Also:
EXCLUSIVE: SCIENTURE HOLDINGS Tells Benzinga Co. Secures Multiple Commercial GPO Agreements, Says Expanding US Market Access For Arbli To More Than 2500 Healthcare Institutions
📈 PositiveBenzinga•Oct 1, 2025, 12:45 PM•Also:
Frequently Asked Questions about SCNX
What is SCNX's current stock price?
Scienture Holdings, Inc. (SCNX) is currently trading at $0.57 per share. The stock has moved +14.47% today.
What is the analyst price target for SCNX?
No analyst price targets are currently available for this stock.
What sector is Scienture Holdings, Inc. in?
Scienture Holdings, Inc. operates in the Healthcare sector, specifically within the Medical - Healthcare Information Services industry. The company is traded on the NASDAQ exchange.
What is SCNX's market cap?
Scienture Holdings, Inc. has a market capitalization of $0.01 billion, making it a small-cap company.
Does SCNX pay dividends?
No, Scienture Holdings, Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorAEON
AEON Biopharma, Inc.
$1.08
Mkt Cap: $0.0B
BFRG
Bullfrog AI Holdings, Inc. Common Stock
$1.13
Mkt Cap: $0.0B
BOLT
Bolt Biotherapeutics, Inc.
$5.16
Mkt Cap: $0.0B
CING
Cingulate Inc.
$3.97
Mkt Cap: $0.0B
EVGN
Evogene Ltd.
$1.02
Mkt Cap: $0.0B
IMNN
Imunon, Inc.
$3.75
Mkt Cap: $0.0B
SNSE
Sensei Biotherapeutics, Inc.
$8.86
Mkt Cap: $0.0B
TNON
Tenon Medical, Inc.
$1.10
Mkt Cap: $0.0B
TRAW
Traws Pharma, Inc.
$1.27
Mkt Cap: $0.0B
XAIR
Beyond Air, Inc.
$0.91
Mkt Cap: $0.0B
Explore stocks similar to SCNX for comparison